Facing myeloma? We're here for you.
Reach out to the InfoLine with your questions at 800-452-2873 (US & Canada) or 1-818-487-7455 (Worldwide) or set up a time at myeloma.org/infoline
Always free. Always here for you.
#MoreThanMyeloma #AsktheIMF
How can you watch for myeloma relapse? Nurse practitioner Beth Faiman explains in this short video. Watch the full thing at https://www.myeloma.org/node/12434
#MoreThanMyeloma #AsktheIMF
Learn more about how myeloma is measured. This March, during Myeloma Action Month, help us raise awareness with #MoreThanMyeloma.
#MyelomaActionMonth #AskTheIMF
Is CAR T-cell therapy getting safer and more effective? New data from ASH 2025 could mean better access, stronger responses, and improved safety for myeloma patients. Dr. Joseph Mikhael breaks down the top 5 updates. Watch now. https://mmsm.link/3MwOaii #AsktheIMF
“Smoldering myeloma and kidney disease”
IMF Chief Medical Officer Dr. Joseph Mikhael answers your questions. Have a question? Comment below. #AskTheIMF
The top 10 most impactful myeloma breakthroughs in CAR T-cell therapy and bispecific antibodies from ASH. Watch now: https://mmsm.link/4qeZrlU
#ASH25 #IMFASH25 #ASKTHEIMF
From #ASH25: We break down the 10 most impactful myeloma breakthroughs, including advances in CAR T-cell therapy and bispecific antibodies and what this latest research means for people living with myeloma. Watch now: mmsm.link/4qeZrlU
#IMFASH25 #ASKTHEIMF
@jmikhaelmd.bsky.social
Besides Zometa, what helps strengthen bones? IMF Chief Medical Officer Dr. Joseph Mikhael answers this patient question in this short clip. Ask your own question in the comments! #AsktheIMF Watch the full Q&A video now at https://www.myeloma.org/node/12210
Have a question for IMF Chief Medical Officer Dr. Joseph Mikhael? Comment below with the hashtag #AsktheIMF. Or, ask our chatbot Myelo your question any time in the bottom right corner on myeloma.org. Plus, find a free event with expert Q&As at events.myeloma.org
Can DARZALEX (daratumumab) be used for maintenance without transplant in myeloma? IMF Chief Medical Officer Dr. Joseph Mikhael breaks it down in this short clip. Watch the full expert Q&A now at https://www.myeloma.org/node/12203 #AsktheIMF
Myeloma community, we want to see you live on 12/8! IMF Chief Medical Officer Dr. Joseph Mikhael & support group leaders will be live at ASH sharing what’s important in myeloma from the latest ASH research. Hit "Going": https://www.facebook.com/events/837237505620824
#AsktheIMF
#ASH25
#IMFASH25
Can you drive 2 'CARs' at the same time?
IMF Chief Medical Officer Dr. Joseph Mikhael shares updates from the International Myeloma Society meeting, including an abstract that gave 2 CAR T-cell therapies together. See his full thoughts at https://www.myeloma.org/node/12174 #AsktheIMF
IMF Chief Medical Officer Dr. Joseph Mikhael shares the latest lessons on myeloma treatment shared at the 2025 International Myeloma Society (IMS) meeting. Follow along with his thoughts on the meeting at https://www.myeloma.org/node/12174 #AsktheIMF
IMF Chief Medical Officer Dr. Joseph Mikhael discusses the latest updates from the 2025 International Myeloma Society (IMS) meeting on high risk multiple myeloma (HRMM). See his extended thoughts on the IMS meeting research at https://www.myeloma.org/node/12174 #AsktheIMF
IMF Chief Medical Officer Dr. Joseph Mikhael shares the highlights of the 2025 International Myeloma Society meeting in this new video. See his full thoughts on the research from this important meeting at https://www.myeloma.org/node/12174 #AsktheIMF
Dr. Joe answers the question: "Can new treatments get approved faster?"
Ask your questions using #AsktheIMF or contact our InfoLine for personalized support at 1-818-487-7455.
"What are the long-term side effects of myeloma treatment?"
Dr. Joe answers the question.
Ask your questions using #AsktheIMF or contact our InfoLine for personalized support at 1-818-487-7455.
Dr. Joe answers the question: "What do #myeloma patients do when they're allergic to steroids?"
Ask your questions using #AsktheIMF or contact our InfoLine for personalized support at 1-818-487-7455.
"Am I at higher risk if my mother and half-sister both had multiple myeloma?"
Ask your questions using #AsktheIMF or contact our InfoLine for personalized support at 1-818-487-7455. Dr. Joe answers the question:
Don't hesitate to reach out to the IMF. We are here for you! Join IMF Chief Medical Officer Dr. Joe on Monday, Sept. 8 for a live Q&A to get your questions answered. RSVP now, hit "Going" at www.facebook.com/events/3757713881192843/... #AsktheIMF #mmsm
In early relapse, patients have more treatment options than ever—whether antibody drug conjugates, or bispecific antibodies These advances, alongside CAR T-cell therapy and triplets, offer richer choices for care. #AskTheIMF
SARCLISA (isatuximab) is being studied with an on-body injector that delivers the drug subcutaneously over 12-15 minutes—no IV needed. A promising new way to make treatment more convenient! #AskTheIMF
"One challenge with this drug is some eye-related side effects like blurry vision. But giving it less frequently lowers this risk. Many patients, especially those not eligible for CAR T, could benefit from Blenrep (belantamab mafodotin) given every 8 to 12 weeks."
#AskTheIMF
In this Q&A, Dr. Joseph Mikhael, Chief Medical Officer of the International Myeloma Foundation, answers real questions from patients and families about smoldering #myeloma, double-hit progression, supplements, and neurological complications. https://www.myeloma.org/node/12071
#AskTheIMF
Quadruplets are now standard upfront for transplant patients, dual maintenance is expanding, MRD is guiding transplant needs, and high-risk patients benefit from continuous aggressive therapy. #AsktheIMF
Late relapse multiple myeloma: Could a one-time CAR T-cell treatment keep myeloma away for 5 years? Dr. Joseph Mikhael shares ASCO/EHA 2025 breakthroughs changing myeloma care. Watch now: https://mmsm.link/45E9isx #AsktheIMF
How do I join a clinical trial for relapsed myeloma? Dr. Joseph Mikhael, Chief Medical Officer of the IMF, answers in this new video. Find a clinical trial at myeloma.org/sparkcures Watch the full video with Dr. Joe at https://www.myeloma.org/node/11799 #AsktheIMF
What questions should you ask your doctor after a myeloma relapse? Dr. Joseph Mikhael, IMF Chief Medical Officer, gives helpful advice and answers other questions on relapsed myeloma in this new video. Watch the full thing now at https://www.myeloma.org/node/11799 #AsktheIMF
Unfortunately, we don't really know the cause of multiple myeloma in most patients. Tune in for the full Q&A video with International Myeloma Foundation Chief Medical Officer Dr. Joseph Mikhael at https://www.myeloma.org/node/11783 & tag #AsktheIMF on social to submit your questions!
You’ve got questions, and IMF Chief Medical Officer @jmikhaelmd.bsky.social has answers! Join us LIVE on Facebook on Saturday, July 19 at 10:15am PST to ask Dr. Joe anything about myeloma. RSVP now at https://www.facebook.com/events/1196152482539505
#AsktheIMF #mmsm
